CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
2.1747
8.48%
  • Summary
  • Historical Data
Trading сonditions
Spread 0.1906
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.026235 %
Charges from full value of position ($-4.98)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026235%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.004012 %
Charges from full value of position ($0.76)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004012%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 2.0047
Open 2.1747
1-Year Change 163.86%
Day's Range 2.0747 - 2.1747
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 19, 2024 2.1747 0.0000 0.00% 2.1747 2.1747 2.0747
Sep 18, 2024 2.0047 -0.1200 -5.65% 2.1247 2.1947 2.0047
Sep 17, 2024 2.1547 -0.0400 -1.82% 2.1947 2.4547 2.0547
Sep 16, 2024 2.1347 -0.1700 -7.38% 2.3047 2.3747 2.0647
Sep 13, 2024 2.2447 0.1000 4.66% 2.1447 2.2447 2.1447
Sep 12, 2024 2.0847 0.0000 0.00% 2.0847 2.2047 2.0847
Sep 11, 2024 2.0147 0.0400 2.03% 1.9747 2.1547 1.9147
Sep 10, 2024 2.0042 0.0200 1.01% 1.9842 2.0842 1.8942
Sep 9, 2024 1.9642 0.0600 3.15% 1.9042 2.0242 1.8542
Sep 6, 2024 1.9042 0.0100 0.53% 1.8942 2.0942 1.8942
Sep 5, 2024 1.9442 0.0900 4.85% 1.8542 1.9642 1.8042
Sep 4, 2024 1.8242 -0.1200 -6.17% 1.9442 1.9842 1.8242
Sep 3, 2024 1.8842 -0.0700 -3.58% 1.9542 1.9542 1.8042
Aug 30, 2024 1.8542 -0.1000 -5.12% 1.9542 1.9542 1.7842
Aug 29, 2024 1.7642 -0.1000 -5.36% 1.8642 1.9142 1.7642
Aug 28, 2024 1.8142 -0.1400 -7.16% 1.9542 1.9742 1.8142
Aug 27, 2024 1.9542 0.0500 2.63% 1.9042 1.9542 1.9042
Aug 26, 2024 1.8942 0.0800 4.41% 1.8142 1.9242 1.8142
Aug 23, 2024 1.8942 0.0000 0.00% 1.8942 1.8942 1.8942
Aug 22, 2024 1.8142 -0.0400 -2.16% 1.8542 1.8742 1.8142

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

BeyondSpring Inc. Company profile

About Beyondspring Inc

BeyondSpring Inc. is a global biopharmaceutical company that is focused on developing immuno-oncology cancer therapies. The Company’s lead product Plinabulin, which is being studied as an anti-cancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). The Plinabulin product is a marine-derived small-molecule selective immunomodulating microtubule-binding agent (SIMBA) with a range of immune activities. Its Plinabulin has the immune defense protein, GEF-H1, which leads to two effects: a durable anti-cancer benefits due to the maturation of dendritic cells resulting in activation of tumor antigen-specific T-cells to target cancer cells and early-onset action in chemotherapy-induced neutropenia (CIN) prevention after chemotherapy by boosting the number of hematopoietic stem/progenitor cells (HSPCs).

Financial summary

BRIEF: For the nine months ended 30 September 2021,Beyondspring Inc revenues increased from $0K to $1M. Netloss increased 26% to $54.7M. Revenues reflect an increasein demand for the Company's products and services due tofavorable market conditions. Higher net loss reflectsGeneral and administrative - Balancing increase from $10.2Mto $22M (expense), Stock-based Compensation in SGA increaseof 76% to $3.7M (expense).

Industry: Bio Therapeutic Drugs

28 Liberty Street
39th Floor
NEW YORK
NEW YORK 10005
US

News

BoE Preview: no change expected but forward guidance will be key

The BoE is forecasted to leave rates unchanged in September as UK CPI remains stubborn.

14:53, 19 September 2024

FOMC Decision Review: A 50 point cut but the markets responded in a mixed fashion

Discover the US Federal Reserve’s latest 50 basis point cut and how the markets reacted. Stocks surged, the US Dollar fell, and the Fed hints at more aggressive cuts ahead.

11:30, 19 September 2024

Bank of Japan Preview

The Bank of Japan will meet on September 20, 2024, with markets anticipating minimal policy changes. However, inflation risks remain, with core CPI at 2.7% and potential for future interest rate hikes.

09:40, 17 September 2024

FOMC Decision Preview

As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.

09:48, 16 September 2024

ECB Preview: cuts expected but the pace is uncertain

Markets expect the ECB to cut rates again in September, but how many more?

12:34, 11 September 2024

Market analysis: US CPI and PPI

Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.

07:56, 10 September 2024

Introducing Newsquawk: your new in-platform newsfeed

We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.

14:09, 20 August 2024

People also watch

XRP/USD

0.59 Price
-0.470% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

US100

19,808.50 Price
-0.030% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

63,811.85 Price
+1.130% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Oil - Crude

71.14 Price
0.000% 1D Chg, %
Long position overnight fee 0.0292%
Short position overnight fee -0.0511%
Overnight fee time 21:00 (UTC)
Spread 0.030

Still looking for a broker you can trust?

Join the 640,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading